Randomised trial of α-tocopherol and β-carotene supplements on incidence of major coronary events in men with previous myocardial infarction

Lancet

Volumn 349, Issue 9067, 1997, Pages 1715-1720

  Rapola, Janne M ^a   Virtamo, Jarmo ^a   Ripatti, Samuli ^a   Huttunen, Jussi K ^a   Albanes, Demetrius ^b   Taylor, Philip R ^b   Heinonen, Olli P ^c  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; BETA CAROTENE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030916162     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)01234-8     Document Type: Article

References (29)

1. Dieber-Rotheneder M, Puhl H, Waeg G, Striegel G, Esterbauer H. Effect of oral supplementation with D-α-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation. J Lipid Res 1991; 32: 1325-32.
2. Princen HM, van Poppel G, Vogelezang C, Buytenhek R, Kok FJ. Supplementation of vitamin E but not beta-carotene in vivo protects low density lipoprotein from lipid peroxidation in vitro. Arterioscler Thromb Vasc Biol 1992; 12: 554-62.
3. Reaven PD, Khouw A, Beltz WF, Parthasarathy S, Witztum JL. Effect of dietary antioxidant combinations in humans. Arterioscler Thromb Vasc Biol 1993; 13: 590-600.
4. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willet WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993; 328: 1450-56.
5. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993; 328: 1444-49.
6. Knekt P, Reunanen A, Järvinen R, Seppänen R, Heliövaara M, Aromaa A. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol 1994; 139: 1180-89.
7. Pandey DK, Shekelle R, Selwyn BJ, Tangney C, Stamler J. Dietary vitamin C and beta-carotene and risk of death in middle-aged men: the Western Electric study. Am J Epidemiol 1995; 142: 1269-78.
8. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996; 334: 1145-49.
9. The Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330: 1029-35.
10. Greenberg ER, Baron JA, Karagas MR, et al. Mortality associated with low plasma concentration of beta carotene and the effect of oral supplementation. JAMA 1996; 275: 699-703.
11. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996; 334: 1150-55.
12. Stephens NG, Parsons A, Schofield PM, et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996; 347: 781-86.
13. Gaziano JM, Manson JE, Ridker PM, Buring JE, Hennekens CH. Beta carotene therapy for chronic stable angina. Circulation 1990; 82 (suppl III): 201.
14. Gaziano JM, Manson JE, Ridker PM, Buring JE, Hennekens CH. Beta carotene therapy for chronic stable angina. Circulation 1996; 94 (suppl I): 508.
15. The ATBC Cancer Prevention Study Group. The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. Ann Epidemiol 1994; 4: 1-10.
16. Milne DB, Botnen J. Retinol, α-tocopherol, lycopene, and alpha- and beta-carotene simultaneously determined in plasma by isocratic liquid chromatography. Clin Chem 1986; 32: 874-76.
17. Rapola JM, Virtamo J, Korhonen P, et al. Validity of diagnoses of major coronary events in national registers of hospital diagnoses and deaths in Finland. Eur J Epidemiol 1997; 13: 133-38.
18. Schlant RC, Forman S, Stamler J, Canner PL. The natural history of coronary heart disease: prognostic factors after recovery from myocardial infarction in 2789 men. Circulation 1982; 66: 401-14.
19. Tervahauta M, Pekkanen J, Nissinen A. Risk factors of coronary heart disease and total mortality among elderly men with and without preexisting coronary heart disease. J Am Coll Cardiol 1995; 26: 1623-29.
20. Kannel WB, Sorlie P, McNamara PM. Prognosis after initial myocardial infarction: the Framingham study. Am J Cardiol 1979; 44: 58-59.
21. Morris SD, Yellon DM. Vitamin E and coronary heart disease. Lancet 1996; 347: 1690.
22. Ambrosio G, Tritto I, Chiariello M. The role of oxygen free radicals in preconditioning. J Mol Cell Cardiol 1995; 27: 1035-39.
23. Sun JZ, Tang XL, Park SW, Qiu Y, Turrens JF, Bolli R. Evidence for an essential role of reactive oxygen species in the genesis of late preconditioning against myocardial stunning in conscious pigs. J Clin Invest 1996; 97: 562-76.
24. Yellon DM, Alkhulaifi AM, Pugsley WB. Preconditioning the human myocardium. Lancet 1993; 342: 276-77.
25. Kloner RA, Yellon D. Does ischemic preconditioning occur in patients? J Am Coll Cardiol 1994; 24: 1133-42.
26. Kloner RA, Shook T, Przyklenk K, et al. Previous angina alters inhospital outcome in TIMI 4. Circulation 1995; 91: 37-45.
27. Prince MR, LaMuraglia GM, MacNichol EF Jr. Increased preferential absorption in human atherosclerotic plaque with oral beta carotene. Circulation 1988; 78: 338-44.
28. Mitchell DC, Prince MR, Frisoli JK, Smith RE, Wood RFM. Beta carotene uptake into atherosclerotic plaque: enhanced staining and preferential ablation with the pulsed dye laser. Lasers Surg Med 1993; 13: 149-57.
29. Jha P, Flather M, Lonn E, Farkouh M, Yusuf S. The antioxidant vitamins and cardiovascular disease. Ann Intern Med 1995; 123: 860-72.